SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-17-136936
Filing Date
2017-04-25
Accepted
2017-04-25 17:05:33
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 d380004ds3.htm S-3 440529
2 EX-4.3 d380004dex43.htm EX-4.3 301046
3 EX-4.4 d380004dex44.htm EX-4.4 109587
4 EX-4.5 d380004dex45.htm EX-4.5 112406
5 EX-4.6 d380004dex46.htm EX-4.6 91490
6 EX-5.1 d380004dex51.htm EX-5.1 28468
7 EX-23.1 d380004dex231.htm EX-23.1 1641
8 GRAPHIC g380004g0425153600926.jpg GRAPHIC 2869
9 GRAPHIC g380004g0425153601082.jpg GRAPHIC 2926
10 GRAPHIC g380004g0425163024237.jpg GRAPHIC 2722
  Complete submission text file 0001193125-17-136936.txt   1098568
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-217459 | Film No.: 17781793
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1